Key result
IV digoxin doubles LVEF decline per heart rate increase vs diltiazem in acute AF.
Why the study?
The relation between heart rate and left ventricular function during rate control in atrial fibrillation is incompletely understood.
Does intravenous digoxin improve left ventricular ejection fraction compared to intravenous diltiazem in patients with symptomatic recent onset rapid atrial fibrillation?
RCT (n=24)
Does intravenous digoxin improve left ventricular ejection fraction compared to intravenous diltiazem in patients with symptomatic recent onset rapid atrial fibrillation?
In patients with acute atrial fibrillation, intravenous digoxin provides similar improvements in left ventricular ejection fraction compared to diltiazem despite less potent heart rate reduction.
Answers are grounded in this paper and cite their sources.
Supports digoxin as alternative to diltiazem in acute AF; extends RCT evidence on agent-specific EF responses.
BACKGROUND: The relation between heart rate and left ventricular function during rate control in atrial fibrillation is incompletely understood. METHODS: Twenty-four patients (age 67 +/- 11 years) with symptomatic recent onset rapid atrial fibrillation and rapid ventricular rate (> 110 bpm) were randomly assigned to receive either intravenous digoxin (13 mcg/kg) or intravenous diltiazem (0.25 mg/kg bolus plus a maintenance infusion). A portable radionuclide detector was used to collect validated measures of relative left ventricular volumes, along with heart rate data, every 15 seconds for 6 hours. RESULTS: Heart rate decreased significantly at 15 minutes and 180 minutes in the diltiazem group (from 133 +/- 18 bpm to 111 +/- 26 bpm [P <.01] to 94 +/- 24 bpm [P <.001]) but not in the digoxin group (from 129 +/- 18 bpm to 126 +/- 17 bpm [P = NS] to 118 +/- 15 bpm [P = NS]). Left ventricular ejection fraction improved in both groups to a similar extent (from 39 +/- 10% to 50 +/- 8%, [P <.05] after diltiazem, and from 38 +/- 8% to 52 +/- 11% [P <.05] after digoxin at baseline vs 180 minutes, respectively). The ejection fraction vs heart rate slope was steeper in the digoxin group than in the diltiazem group (-0.34 +/- 0.18 vs -0.16 +/- 0.17, P =.048) indicating a more pronounced improvement in ejection fraction per unit decrease in heart rate. CONCLUSION: In patients with acute atrial fibrillation, digoxin led to similar improvements in ejection fraction compared to diltiazem despite a slower and less potent heart rate slowing.
No takes yet. Share an insight, caveat, or question.
Pintér et al. (2003) conducted an RCT in symptomatic recent onset rapid atrial fibrillation and rapid ventricular rate (> 110 bpm) (n=24). intravenous digoxin vs. intravenous diltiazem was evaluated on ejection fraction vs heart rate slope (p=0.048). Intravenous digoxin resulted in a steeper ejection fraction vs heart rate slope compared to diltiazem in patients with acute atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: